Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 10-748 Olsztyn, Poland.
Institute of Biomedicine, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
Int J Mol Sci. 2023 Sep 27;24(19):14632. doi: 10.3390/ijms241914632.
Vitamin D is a pre-hormone that regulates hundreds of target genes and dozens of physiological functions, including calcium homeostasis and the activity of the immune system, via its metabolite 1,25-dihydroxyvitamin D, which is a high-affinity ligand for the transcription factor vitamin D receptor. In this study, we took advantage of data from the VitDHiD vitamin D intervention trial (25 healthy individuals) indicating that 442 protein-coding genes were significantly (false discovery rate < 0.05) up- or downregulated in peripheral blood mononuclear cells one day after taking a vitamin D bolus. Since more than half of the encoded proteins had "signaling" assigned as a primary biological function, we evaluated their involvement in signal transduction cascades included in the KEGG (Kyoto Encyclopedia of Genes and Genomes) database and found 88 of the vitamin D targets contributing to 16 different pathways. Eight of the pathways show an approximately even contribution of up- and downregulated genes, suggesting that the actions of vitamin D stabilize homeostasis of the physiological processes driven by the respective signaling cascades. Interestingly, vitamin D target genes involved in the signaling pathways of hypoxia-inducible factor 1 (HIF1), tumor necrosis factor (TNF), mitogen-activated protein kinases (MAPKs) and nuclear factor κB (NFκB) are primarily downregulated. This supports the observation that the physiological role of vitamin D in healthy individuals is to tone down certain processes rather than activate them. In conclusion, under in vivo conditions, vitamin D either alleviates the homeostasis of immune cells in healthy individuals or counteracts molecular responses to oxygen deprivation (HIF1), microbe infection (TNF), growth stimulation (MAPKs) and inflammation (NFκB).
维生素 D 是一种前激素,通过其代谢产物 1,25-二羟维生素 D,调节数百个靶基因和数十种生理功能,包括钙稳态和免疫系统的活性,而 1,25-二羟维生素 D 是转录因子维生素 D 受体的高亲和力配体。在这项研究中,我们利用来自 VitDHiD 维生素 D 干预试验(25 名健康个体)的数据,表明在服用维生素 D 冲击剂一天后,外周血单核细胞中有 442 个蛋白编码基因显著(错误发现率 < 0.05)上调或下调。由于超过一半的编码蛋白被分配为“信号”作为主要生物学功能,我们评估了它们在 KEGG(京都基因与基因组百科全书)数据库中包含的信号转导级联中的参与情况,并发现 88 个维生素 D 靶标参与了 16 种不同的途径。这 8 条途径显示出上调和下调基因的大致均匀贡献,表明维生素 D 的作用稳定了由各自信号级联驱动的生理过程的动态平衡。有趣的是,涉及缺氧诱导因子 1(HIF1)、肿瘤坏死因子(TNF)、丝裂原激活蛋白激酶(MAPKs)和核因子 κB(NFκB)信号通路的维生素 D 靶基因主要下调。这支持了这样的观察结果,即在健康个体中,维生素 D 的生理作用是减轻某些过程的作用,而不是激活它们。总之,在体内条件下,维生素 D 要么缓解健康个体免疫细胞的动态平衡,要么对抗对缺氧(HIF1)、微生物感染(TNF)、生长刺激(MAPKs)和炎症(NFκB)的分子反应。